Israel Englander’s Palisade Bio PALI Stock Holding History

Israel Englander’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.95M	Sell	934,155 -1,169,198	-56%	-$2.3M	﹤0.01%	3842
2026 Q1	$3.68M	Buy	2,103,353 +1,808,867	+614%	+$3.29M	﹤0.01%	3277
2025 Q4	$692K	Buy	+294,486	New	+$566K	﹤0.01%	4739
2024 Q2	–	Sell	-1,213	Closed	-$7.26K	–	6359
2024 Q1	$7.26K	Buy	+1,213	New	+$8.46K	﹤0.01%	5969
2022 Q4	–	Sell	-91	Closed	-$7K	–	6912
2022 Q3	$7K	Buy	91 +66	+264%	+$14K	﹤0.01%	6739
2022 Q2	$8K	Buy	+25	New	+$12K	﹤0.01%	6725
2017 Q2	–	Hold	0	–	-$62K	–	3749
2017 Q1	–	Hold	0	–	–	–	3367
2016 Q2	–	Hold	0	–	-$183K	–	3460
2016 Q1	–	Hold	0	–	–	–	2979
2015 Q4	–	Sell	-1	Closed	-$1.35M	–	2830
2015 Q3	$816K	Hold	1	–	–	﹤0.01%	2400
2015 Q2	$1.47M	Buy	+1	New	+$2.18M	﹤0.01%	2076
2014 Q3	–	Hold	0	–	-$1.18M	–	3925
2014 Q2	–	Hold	0	–	–	–	2104
2014 Q1	–	Hold	0	–	–	–	3333

Other funds holding PALI

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Israel Englander's PALI Position: Q2 2026 in Review

Israel Englander reduced its Palisade Bio (PALI) stake by 56% in Q2 2026, selling an estimated $2.3M and leaving 934,155 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #3842.

Israel Englander first reported a position in PALI in Q2 2015 and has held it in 8 quarters since. The position peaked at $3.68M in Q1 2026. 123 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

Israel Englander held 934,155 shares of Palisade Bio worth $1.95M as of Q2 2026.
Israel Englander sold 1,169,198 Palisade Bio shares in Q2 2026, an estimated $2.3M.
Palisade Bio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3842 holding.
Israel Englander first reported a position in Palisade Bio in Q2 2015 and has held it in 8 quarters since.
Israel Englander's Palisade Bio position peaked at $3.68M in Q1 2026.
123 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.